| 590 |
Centers for Disease Control and Prevention |
Html |
en |
Disability and Health - Healthy Living |
CDC's Public Health Grand Rounds explored disability in health and practice. Read the full article here. View the December 2012 presentation. |
| mental health | 0.464332 |
| disability | 0.400391 |
| healthy life | 0.428341 |
| healthy choices | 0.392619 |
| major muscle groups | 0.390953 |
| Traumatic Brain Injury | 0.450949 |
| active lives | 0.361705 |
| healthy lifestyles | 0.393192 |
| activity increases heart | 0.410419 |
| daily living activities | 0.392307 |
| health care professionals | 0.495981 |
| physical activity guidelines | 0.425357 |
| greater risk | 0.407798 |
| sexual health | 0.372624 |
| sexual assault | 0.381638 |
| Adult Mental Health | 0.413755 |
| health programs | 0.389299 |
| daily life | 0.390994 |
| health records | 0.381408 |
| moderate-intensity activity | 0.367168 |
| aerobic physical activity | 0.476833 |
| Physical violence | 0.364101 |
| health problems | 0.387265 |
| regular physical activity | 0.424575 |
| professional’s office | 0.426459 |
|
| CDC Healthy Weight | 0.4244 |
| United States | 0.401755 |
| adults | 0.387441 |
| Eat healthy foods | 0.431781 |
| important health benefits | 0.418673 |
| victimization | 0.383358 |
| Current Cigarette Smoking | 0.393837 |
| additional health benefits | 0.417704 |
| healthy portions | 0.386676 |
| CDC Physical Activity | 0.430226 |
| health care workers | 0.425138 |
| health care | 0.98732 |
| sexual violence | 0.38946 |
| vigorous-intensity activity | 0.367528 |
| Teen Mental Health | 0.414064 |
| health concerns | 0.375382 |
| Fact Sheet | 0.384449 |
| people | 0.485774 |
| medical care | 0.362287 |
| physical activity | 0.810812 |
| disabilities | 0.597334 |
| Sexually Transmitted Diseases | 0.38428 |
| possible health care | 0.439749 |
| physical activities | 0.367353 |
|
CLICK HERE |
| 706 |
Centers for Disease Control and Prevention |
Html |
en |
Progress Toward Poliomyelitis Eradication - Nigeria, January2012-September 2013 |
Persons using assistive technology might not be able to fully access information in this file. For assistance, please send e-mail to: mmwrq@cdc.gov. |
| global polio eradication | 0.728652 |
| trivalent oral polio | 0.659841 |
| environmental surveillance | 0.633338 |
| vaccine-derived poliovirus type | 0.762809 |
| SIAs | 0.701453 |
| AFP cases | 0.656304 |
| polio eradication activities | 0.700148 |
| high-risk states | 0.653752 |
| considerable progress | 0.641353 |
| positive sewage samples | 0.719197 |
| Kano | 0.66787 |
| routine immunization | 0.702938 |
| supplemental immunization activities | 0.785212 |
| north central states | 0.68982 |
| polio cases | 0.772385 |
| four-category pass/fail scheme | 0.671741 |
| LGAs | 0.734122 |
| adequate stool specimens | 0.677596 |
| WPV cases | 0.702968 |
| AFP surveillance | 0.771567 |
| routine immunization coverage | 0.695198 |
| major capsid protein | 0.668256 |
| polio supplemental immunization | 0.663426 |
| high-risk northern states | 0.631696 |
| polio eradication | 0.914894 |
|
| genetic clusters | 0.628183 |
| wild poliovirus | 0.830944 |
| wild poliovirus type | 0.77189 |
| states | 0.756922 |
| polio eradication program | 0.673918 |
| recent polio cases | 0.711758 |
| Nigeria | 0.789769 |
| Nigeria Office. Serigne | 0.641281 |
| Federal Capital Territory | 0.668633 |
| cases | 0.891598 |
| low WPV transmission | 0.634001 |
| effective outbreak response | 0.764492 |
| local government areas | 0.930407 |
| polio workers | 0.698814 |
| SIA quality | 0.7352 |
| poor SIA implementation | 0.636353 |
| WPV type | 0.637931 |
| nonpolio AFP rate | 0.696672 |
| oral polio vaccine | 0.79587 |
| genomic sequence analysis | 0.665183 |
| WPV transmission | 0.913267 |
| key polio eradication | 0.675695 |
| low SIA quality | 0.638432 |
| polio eradication efforts | 0.646053 |
|
CLICK HERE |
| 880 |
Centers for Disease Control and Prevention |
Html |
en |
Global Health Strategy | CDC Features |
CDC’s Global Health Strategy outlines how CDC will leverage its core strengths to advance four overarching global health goals in the areas of Health Impact, Health Security, Health Capacity, and Organizational Capacity. |
| CDC | 0.870392 |
| principal partners | 0.47733 |
| U.S. Government agencies | 0.537596 |
| global health strategy | 0.931909 |
| health impact | 0.650189 |
| workforce development | 0.479637 |
| global health goals | 0.722666 |
| deep technical expertise | 0.544916 |
| disease surveillance | 0.477327 |
| longer lives | 0.492796 |
| global health | 0.939388 |
| health systems | 0.523101 |
| World Health Organization | 0.593461 |
| public health emergencies | 0.622042 |
| non-communicable disease | 0.485516 |
| health challenges | 0.52656 |
| CDC works | 0.643765 |
| global public health | 0.63114 |
| health laboratory capacity | 0.627632 |
| UNICEF). | 0.482216 |
| Health Security | 0.599259 |
| health threats | 0.532964 |
| United States | 0.481876 |
| public health institutions | 0.598848 |
|
| United Nations Children | 0.54484 |
| Global Programs | 0.503103 |
| health information systems | 0.589705 |
| technical rigor | 0.487401 |
| non-governmental organizations | 0.558562 |
| technical assistance | 0.478511 |
| special partnerships | 0.488958 |
| operational research | 0.477524 |
| public health goals | 0.615641 |
| public health | 0.979569 |
| global health engagement | 0.614044 |
| public health programs | 0.602437 |
| public health actions | 0.600826 |
| global health work | 0.599909 |
| CDC Global Health | 0.769129 |
| core strengths | 0.500121 |
| evidence-based public health | 0.640023 |
| greatest assets | 0.477661 |
| public health capacity | 0.659433 |
| infectious disease | 0.48683 |
| unique expertise | 0.480335 |
| -specific areas | 0.477811 |
| Organizational Capacity | 0.6065 |
| global health agenda | 0.596169 |
|
CLICK HERE |
| 7500 |
Centers for Disease Control and Prevention |
Html |
en |
Health Studies Branch Disaster Response Activities |
The Health Studies Branch (HSB) provides expertise and leadership in epidemiology to local, state, federal and international partners to help them prepare for and respond to natural and man-made public health disasters. To do this, HSB conducts surveillance, rapid needs assessments, epidemiology studies, and provides training in disaster epidemiology to public health professionals. |
| public health issues | 0.419898 |
| Sentinel Site Surveillance | 0.421825 |
| Public Health Emergency | 0.646024 |
| mental health | 0.336246 |
| clinic surveillance sites | 0.42248 |
| CDC Emergency Operations | 0.555793 |
| oil spill | 0.342352 |
| Disease Control | 0.346284 |
| public health surveillance | 0.499059 |
| population—can increase mortality | 0.346461 |
| initial CASPER | 0.352786 |
| surveillance data | 0.415355 |
| Gulf coast counties | 0.34752 |
| carbon monoxide | 0.347908 |
| local emergency coordinators | 0.343834 |
| Emergency Operations Center | 0.507896 |
| Community Assessments | 0.350822 |
| surveillance desk | 0.423261 |
| international public health | 0.454353 |
| physical health | 0.336376 |
| ice storm | 0.338534 |
| public health response | 0.454744 |
| CDC HSB staff | 0.460888 |
| health effects | 0.337393 |
|
| Mississippi state health | 0.419194 |
| shelter surveillance | 0.349805 |
| Mobile Offshore Drilling | 0.348812 |
| American Samoa Department | 0.343451 |
| State Health Services | 0.392265 |
| state-based surveillance systems | 0.432649 |
| heat-related deaths | 0.406588 |
| potential health hazards | 0.402862 |
| Surveillance team | 0.357822 |
| surveillance | 0.535545 |
| Disaster Surveillance Workgroup | 0.444949 |
| public health needs | 0.499328 |
| community public health | 0.497046 |
| local health departments | 0.40015 |
| public health | 0.907901 |
| Health Emergency Response | 0.650671 |
| disaster-related mortality surveillance | 0.418988 |
| basic public health | 0.42099 |
| largest marine petroleum | 0.35428 |
| drop-in surveillance | 0.352789 |
| discernable reported injury | 0.350688 |
| public health messages | 0.409029 |
| rapid needs assessments | 0.484863 |
| disaster response | 0.764943 |
|
CLICK HERE |
| 7589 |
Centers for Disease Control and Prevention |
Html |
en |
Use of 13-Valent Pneumococcal Conjugate Vaccine and 23-Valent Pneumococcal Polysaccharide Vaccine for Adults with Immunocompromising Conditions: Recommendations of the Advisory Committee on Immunization Practices (ACIP) |
Persons using assistive technology might not be able to fully access information in this file. For assistance, please send e-mail to: mmwrq@cdc.gov. |
| 13-valent pneumococcal conjugate | 0.562264 |
| Pneumococcal vaccine-naУÐ?ve persons | 0.549516 |
| HIV-infected persons | 0.545394 |
| vaccine efficacy | 0.684586 |
| initial study dose | 0.643175 |
| polysaccharide vaccine | 0.797614 |
| implemented vaccine program | 0.582662 |
| advisory committee | 0.698795 |
| one-time revaccination dose | 0.571822 |
| cochlear implants | 0.68499 |
| pneumococcal conjugate vaccine | 0.861952 |
| 7-valent pneumococcal conjugate | 0.590916 |
| previous PPSV23 dose | 0.617488 |
| persons | 0.589881 |
| current PPSV23 recommendations | 0.570256 |
| dose | 0.678622 |
| Conjugate pneumococcal vaccine | 0.609656 |
| PCV13 dose | 0.614379 |
| PCV13 vaccine efficacy | 0.648678 |
| high risk | 0.546941 |
| pneumococcal polysaccharide vaccine | 0.737038 |
| CSF leaks | 0.64147 |
| single dose | 0.583541 |
| pneumococcal vaccination opportunity | 0.534862 |
| United States | 0.702259 |
|
| adults | 0.967119 |
| immunocompromising conditions | 0.79022 |
| 23-valent pneumococcal polysaccharide | 0.650772 |
| invasive pneumococcal disease | 0.61783 |
| HIV-infected adults | 0.861418 |
| Immunization Practices | 0.66214 |
| immunocompromised adults | 0.634655 |
| vaccine serotypes | 0.590239 |
| previous PPSV23 vaccination | 0.561799 |
| anatomic asplenia | 0.576984 |
| capsular polysaccharide vaccine | 0.600014 |
| general U.S. HIV-infected | 0.566591 |
| HIV-1-infected Ugandan adults | 0.542206 |
| vaccine group | 0.569474 |
| PPSV23 dose | 0.622493 |
| unpublished data | 0.554776 |
| adverse events | 0.553304 |
| polysaccharide pneumococcal vaccines | 0.551719 |
| acip recommendations | 0.643709 |
| ACIP PPSV23 recommendations | 0.639817 |
| new ACIP recommendations | 0.618338 |
| PPSV23 | 0.675988 |
| et al | 0.792518 |
| IPD | 0.613935 |
|
CLICK HERE |
| 7658 |
Centers for Disease Control and Prevention |
Html |
en |
CDC History Collection |
David J. Sencer CDC Museum |
| Rollins School | 0.366064 |
| key agent | 0.342122 |
| Public Health | 0.3439 |
| global disease prevention | 0.548823 |
| rich heritage | 0.396764 |
| different subject | 0.336088 |
| web site | 0.338167 |
| Emory University | 0.357485 |
| Global Health Institute | 0.552063 |
|
| store three-dimensional objects | 0.611864 |
| audio recordings | 0.367155 |
| historic materials | 0.397437 |
| oral histories | 0.37325 |
| digital history | 0.341891 |
| Collections Manager | 0.357391 |
| J. Sencer CDC | 0.915408 |
| Global Health Chronicles | 0.584467 |
| extensive collection | 0.347692 |
|
CLICK HERE |
| 8012 |
Centers for Disease Control and Prevention |
Html |
en |
Interpersonal and Sexual Violence by Sexual Orientation |
CDC releases data on interpersonal and sexual violence by sexual orientation |
| CDC Director | 0.50629 |
| Sexual Violence Survey | 0.675142 |
| female bisexual victims | 0.566447 |
| sexual orientation | 0.866206 |
| higher prevalence | 0.512072 |
| National Intimate Partner | 0.590074 |
| study details | 0.482536 |
| visit http://www.cdc.gov/violenceprevention/nisvs/index.html | 0.480565 |
| IPV | 0.510944 |
| heterosexual women | 0.510433 |
| Disease Control | 0.506214 |
| national data | 0.490483 |
| female heterosexual victims | 0.559109 |
| Summary findings | 0.48178 |
| sexual assault | 0.493174 |
| Injury Center | 0.487448 |
| national prevalence data | 0.607941 |
| impact LGB individuals | 0.567049 |
| prevention programs | 0.488062 |
| opposite-sex partners | 0.494879 |
| respondents | 0.452635 |
| visit PreventConnect | 0.479899 |
| domestic violence | 0.571778 |
| HUMAN SERVICES | 0.484249 |
| interpersonal violence | 0.584448 |
|
| lesbians | 0.464559 |
| United States | 0.491224 |
| stalking | 0.461777 |
| percent | 0.529399 |
| heavy toll | 0.492111 |
| U.S. DEPARTMENT | 0.486206 |
| primary prevention | 0.482981 |
| intimate partner. | 0.512952 |
| lifetime victimization | 0.523972 |
| male perpetrators | 0.601573 |
| sexual violence | 0.933494 |
| opposite sex couples | 0.573888 |
| female perpetrators | 0.516588 |
| SV | 0.501617 |
| key findings | 0.490471 |
| bisexual women | 0.57746 |
| adverse health consequences | 0.555838 |
| national online project | 0.552385 |
| physical violence | 0.613357 |
| gay men | 0.587701 |
| Nearly half | 0.481766 |
| intimate partner violence | 0.86527 |
| report | 0.4459 |
| Dr. Tom Frieden | 0.575612 |
|
CLICK HERE |
| 8869 |
Centers for Disease Control and Prevention |
Html |
en |
Coronavirus - Related Materials - MERS-CoV - CDC |
CDC Coronavirus: Coronaviruses are common throughout the world. They can infect people and animals. Five different coronaviruses can infect people and make them sick. They usually cause mild to moderate upper-respiratory illness. |
| Müller MA | 0.340365 |
| MERS-CoV | 0.341197 |
| east respiratory syndrome | 0.930727 |
| dromedary camels | 0.347911 |
| respiratory distress syndrome | 0.378768 |
| Emerg Infect Dis. | 0.534094 |
| novel coronavirus | 0.49629 |
| respiratory syndrome antibodies | 0.380737 |
| A. Middle East | 0.348696 |
| East Respiratory Syndrome. | 0.395971 |
| Lancet Infect Dis. | 0.338426 |
| World Health Organization | 0.344702 |
| coronavirus seroprevalence | 0.384241 |
| Syndrome Coronavirus Released | 0.432626 |
| syndrome coronavirus illness | 0.417668 |
| syndrome coronavirus infections | 0.42833 |
| Clin Infect Dis. | 0.378313 |
| severe respiratory disease | 0.395084 |
| newly discovered coronavirus | 0.394054 |
| Respiratory Illness Associated | 0.397654 |
| saudi arabia | 0.450806 |
| primary Middle East | 0.346975 |
| United States | 0.368911 |
| Press Briefing Transcript | 0.352475 |
| Novel Coronavirus Investigation | 0.409275 |
|
| Middle East | 0.752497 |
| M. Novel coronavirus | 0.403471 |
| Health Care Providers | 0.338852 |
| Memish ZA | 0.343664 |
| MERS coronavirus | 0.440377 |
| public health | 0.357157 |
| health care | 0.351269 |
| acute respiratory illness | 0.38989 |
| Coronavirus Emergency | 0.398605 |
| Middle East Respiratory | 0.722701 |
| Euro Surveill. | 0.417809 |
| Acute Respiratory Syndrome | 0.376816 |
| United Arab Emirates | 0.336722 |
| CDC Press Briefing | 0.357329 |
| CDC Press Release | 0.357649 |
| novel coronavirus infections | 0.407481 |
| respiratory syndrome coronavirus | 0.941645 |
| syndrome coronavirus infection | 0.497394 |
| severe respiratory illness | 0.484447 |
| et al | 0.652569 |
| MERS coronavirus cases | 0.406205 |
| novel human coronavirus | 0.423357 |
| CDC. Severe respiratory | 0.370715 |
| syndrome coronavirus disease | 0.413023 |
|
CLICK HERE |
| 14226 |
Centers for Disease Control and Prevention |
Html |
null |
Cómo protegerse | El virus del Zika | CDC |
Información sobre el virus del Zika. Facilitada por los Centros para el Control y la Prevención de Enfermedades de los EE. UU. |
|
|
CLICK HERE |
| 14414 |
Centers for Disease Control and Prevention |
Html |
es |
Virus del papiloma humano (VPH) y el cáncer orofaríngeo | Sexually |
Virus del papiloma humano (VPH) y el cáncer orofaríngeo: Hoja informativa de CDC |
| Archivo Apple Quicktime | 0.44969 |
| Archivo RealPlayer | 0.430459 |
| beso francés | 0.433362 |
| Archivo Microsoft PowerPoint | 0.453181 |
| Archivo Adobe PDF | 0.449079 |
| alto riesgo | 0.434727 |
| VPH tipo | 0.614162 |
|
| Estados Unidos | 0.599104 |
| Archivo Microsoft | 0.540588 |
| Archivo Microsoft Word | 0.452653 |
| Archivo Zip Comprimido | 0.449129 |
| Archivo Microsoft Excel | 0.448751 |
| cánceres orofarÃngeos | 0.978428 |
|
CLICK HERE |